Compliance services
Clinical
R&D
MFG
Risk-Based
Compliance
Commercial
Sales
& Marketing
Government
Programs
Contracts
CalcPartner
& ClaimsPartner
Assessment
&
Audit
COT & PHS
Validation
PCX
Features
Drug companies that do not
have a
Compliance Program in place, may soon pay a very high price. Download
the white paper, Building
a
Compliance
Program.
PharmaComplianceXchange (PCX)
|
EVERGREEN Compliance.
The
concept of “commercial compliance” in U.S. pharmaceutical manufacturing
has evolved very quickly over the past several years -- as seen by
increased regulatory requirements and government scrutiny -- and is a
required component of a company’s corporate compliance program. A
commercial compliance program should start with a compliance
infrastructure that aligns to guidance developed by the Office of
Inspector General (OIG), and also includes well-documented policies and
procedures at the business level.
programs
that thrive in all regulatory climates,
THROUGH all business seasons
CIS' experts have
thorough knowledge and understanding of OIG and U.S. FDA
regulations
and
guidelines, as well as industry practices and
related state laws and regulations. We work with clients to
develop and/or evaluate business processes and protocols to ensure that
they support "evergreen" compliance, that is, a program
that will
remain compliant throughout the year in spite of legislative changes,
changes in business process, or changes in business models.

Read more about how CIS can assist
you in developing and maintaining your compliance program.
|